Replies to post #239957 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

senti, what L info BMY was shared by LP in your opinion?

The BMY info shared was from a recent article re: Nivolumab 4 year life expectancies on trials. The article was paid for by BMY and the link was posted on here the other day. That's the post I was responding to. I have no idea what LP might have shared with BMY... if anything.

How did BMY/NIH became partners in the UCLA combo trial to be started in Dec?

I don't know, but I do know the trial is simply being updated.

Why BMY is not chipping in any money to us?

I don't have any idea how much funding they are chipping in as I believe any monies will be given to UCLA.

Why they want a free ride?

Again, I don't know what the financial situation is for that trial... but it's been my observation that most Big Pharmas are always looking for a free ride. Maybe even sometimes with a little help from their hedge fund buddies.

I didn't compare the 4yrOS from that article with that of blended L.

No, I don't believe anyone has. First off, the 4 year OS is for a variety of trials, not GBM. So I'm not sure if any comparisons would even be appropriate.

Really a Tsunami? that big??

It's just hyperbole-speak, bouncing off the previous post. :)